Stock Taper
Materialise NV offers additive manufacturing software, medical solutions, and 3D printing services globally across software, medical, and manufacturing segments for various industries.

Materialise NV now offers custom PEEK implants for cranio-maxillofacial reconstructions, providing a non-metallic alternative to titanium within their integrated digital workflow to enhance surgical outcomes.
At the Formnext 2025 trade show, Materialise unveiled a significant expansion of its CO-AM open and secure software ecosystem, introducing three new solutions and new automation tools. This strategic announcement was notable for its aim to improve workflow interoperability and scale industrial 3D printing, reinforcing the company's manufacturing-oriented approach to industrialization.
In a significant move to enhance its market presence and shareholder value, Materialise announced its intention to pursue an additional listing of its ordinary shares on Euronext Brussels, while maintaining its existing Nasdaq listing. This was coupled with the board's approval of an American Depositary Shares (ADS) buyback program of up to €30 million.
Overall rating: B
| PEER | PRICE | |
|---|---|---|
XMTR | $105.50 | COMPARE |
PRLB | $92.17 | COMPARE |
RXT | $4.17 | COMPARE |
PUBM | $18.42 | COMPARE |
MITK | $17.63 | COMPARE |
SSYS | $8.04 | COMPARE |
DDD | $3.31 | COMPARE |
RMNI | $4.12 | COMPARE |